Lovrencic-Huzjan Arijana, Rundek Tatjana, Katsnelson Michael
University Department of Neurology, University Hospital Center "Sisters of Mercy," 10000 Zagreb, Croatia.
Stroke Res Treat. 2012;2012:175869. doi: 10.1155/2012/175869. Epub 2012 May 7.
Stroke is a one of the leading causes of morbidity and mortality in the world. Carotid atherosclerosis is recognized as an important factor in stroke pathophysiology and represents a key target in stroke prevention; multiple treatment modalities have been developed to battle this disease. Multiple randomized trials have shown the efficacy of carotid endarterectomy in secondary stroke prevention. Carotid stenting, a newer treatment option, presents a less invasive alternative to the surgical intervention on carotid arteries. Advances in medical therapy have also enabled further risk reduction in the overall incidence of stroke. Despite numerous trials and decades of clinical research, the optimal management of symptomatic and asymptomatic carotid disease remains controversial. We will attempt to highlight some of the pivotal trials already completed, discuss the current controversies and complexities in the treatment decision-making, and postulate on what likely lies ahead. This paper will highlight the complexities of decision-making optimal treatment recommendations for patients with symptomatic and asymptomatic carotid stenosis.
中风是全球发病和死亡的主要原因之一。颈动脉粥样硬化被认为是中风病理生理学中的一个重要因素,是中风预防的关键靶点;已开发出多种治疗方式来对抗这种疾病。多项随机试验表明颈动脉内膜切除术在二级中风预防中的疗效。颈动脉支架置入术是一种较新的治疗选择,是对颈动脉进行手术干预的侵入性较小的替代方法。药物治疗的进展也进一步降低了中风的总体发病率。尽管进行了大量试验和数十年的临床研究,但有症状和无症状颈动脉疾病的最佳管理仍存在争议。我们将试图强调一些已经完成的关键试验,讨论治疗决策中当前的争议和复杂性,并推测未来可能的情况。本文将强调为有症状和无症状颈动脉狭窄患者做出最佳治疗建议的决策复杂性。